Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gardner

Showing results (991-1000 of 1,053) with videos related to

Pageof 106
Sort By:
Journal of Pediatric Surgery|November 1, 1996
Is delayed surgery really better for congenital diaphragmatic hernia?: a prospective randomized clinical trialM N de la Hunt, N Madden, J E Scott, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Science Translational Medicine|August 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Scientific Reports|December 14, 2017
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preferenceQing-Rong Liu, Ana Canseco-Alba, Hai-Ying Zhang, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Science (New York, N.Y.)|August 20, 2016
Design, synthesis, and testing toward a 57-codon genomeNili Ostrov, Matthieu Landon, Marc Guell, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.
Human Molecular Genetics|January 14, 2009
Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophyMegan L Landsverk, Elizabeth K Ruzzo, Heather C Mefford, et al.
Science Translational Medicine|October 1, 2025
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaquesL K Metthew Lam, Theron Gilliland, Matthew Dunn, et al.
Pageof 106

Showing results (991-1000 of 1,053) with videos related to

Sort By:
Pageof 106
Journal of Pediatric Surgery|November 1, 1996
Is delayed surgery really better for congenital diaphragmatic hernia?: a prospective randomized clinical trialM N de la Hunt, N Madden, J E Scott, et al.
Neuro-Oncology Advances|November 16, 2022
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapySharon L Gardner, Rohinton S Tarapore, Jeffrey Allen, et al.
Science Translational Medicine|August 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Scientific Reports|December 14, 2017
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preferenceQing-Rong Liu, Ana Canseco-Alba, Hai-Ying Zhang, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Science (New York, N.Y.)|August 20, 2016
Design, synthesis, and testing toward a 57-codon genomeNili Ostrov, Matthieu Landon, Marc Guell, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.
Human Molecular Genetics|January 14, 2009
Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophyMegan L Landsverk, Elizabeth K Ruzzo, Heather C Mefford, et al.
Science Translational Medicine|October 1, 2025
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaquesL K Metthew Lam, Theron Gilliland, Matthew Dunn, et al.
Pageof 106